Jeff Yass’s MediciNova MNOV Stock Holding History

Jeff Yass’s Portfolio MNOV Stock Details MNOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-10,700	Closed	-$22.4K	–	12935
2023 Q3	$22.4K	Sell	10,700 -4,600	-30%	-$10.7K	﹤0.01%	11573
2023 Q2	$35.2K	Buy	+15,300	New	+$33.7K	﹤0.01%	11468
2022 Q1	–	Sell	-14,800	Closed	-$40K	–	13607
2021 Q4	$40K	Sell	14,800 -22,900	-61%	-$76.5K	﹤0.01%	12660
2021 Q3	$143K	Buy	37,700 +14,200	+60%	+$54K	﹤0.01%	11828
2021 Q2	$100K	Sell	23,500 -18,300	-44%	-$78.8K	﹤0.01%	12099
2021 Q1	$211K	Sell	41,800 -18,000	-30%	-$105K	﹤0.01%	11330
2020 Q4	$315K	Buy	+59,800	New	+$343K	﹤0.01%	9160
2018 Q3	–	Sell	-10,300	Closed	-$82K	–	9852
2018 Q2	$82K	Buy	+10,300	New	+$106K	﹤0.01%	9123
2017 Q1	–	Sell	-10,800	Closed	-$65K	–	9566
2016 Q4	$65K	Buy	+10,800	New	+$76.1K	﹤0.01%	9222

Other funds holding MNOV

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Jeff Yass's MNOV Position: Q2 2026 in Review

Jeff Yass reduced its MediciNova (MNOV) stake by 39% in Q2 2026, selling an estimated $23.6K and leaving 26,752 shares worth $35.3K. The position accounts for ﹤0.01% of the portfolio, ranked #12926.

Jeff Yass first reported a position in MNOV in Q1 2016 and has held it in 28 quarters since. The position peaked at $771K in Q1 2016. 29 funds tracked by Wall St. Rank hold MNOV as of Q2 2026.

Jeff Yass held 26,752 shares of MediciNova worth $35.3K as of Q2 2026.
Jeff Yass sold 17,174 MediciNova shares in Q2 2026, an estimated $23.6K.
MediciNova made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #12926 holding.
Jeff Yass first reported a position in MediciNova in Q1 2016 and has held it in 28 quarters since.
Jeff Yass's MediciNova position peaked at $771K in Q1 2016.
29 funds tracked by Wall St. Rank held MediciNova as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.